Articles Published in 2008

Algorithme Gets 240 Bed Phase I Unit from BASi

Thursday, July 10, 2008 02:44 PM

Bioanalytical Systems (BASi) sold its Baltimore-based clinical pharmacology research unit to Montreal, Canada-based phase I/bioequivalence CRO Algorithme. BASi sold the 68,000-square-foot, 240-bed unit for $850,000 in cash. Since it is BASi’s only early phase research facility, BASi is exiting the phase I first-in-human clinical trials market. The company is primarily a preclinical, bioanalytical and immuno-assay services firm. It also manufactures specialized equipment for liquid chromatography, in vivo sampling, veterinary medicine and electrochemistry.

More... »

Medidata Aspiring to Win Over CRO Market

Tuesday, July 8, 2008 06:05 AM

As the industry enters a period of eClinical consolidation — ClinPhone and Datalabs, PharmaLinkFHI and Matrix Contract Research, Parexel and Green Mountain Logic — and as the adoption of these technologies swells, not only has the playing field narrowed for these companies, but the game itself is changing.

More... »

CWWeekly June 30th 2008 Issue

Monday, July 7, 2008 10:32 AM

Top News

More... »

Quintiles Will Not Pursue ClinPhone Acquisition, Parexel’s Offer Stands

Wednesday, July 2, 2008 12:47 PM

Durham, N.C.-based contract research organization (CRO) Quintiles stated it will not counter Waltham, Mass.-based rival CRO Parexel’s bid for the acquisition of ClinPhone, a clinical technology company based in the UK. Parexel’s offer is $182 million in cash, an 86% premium over ClinPhone's share price.

More... »

eClinical Round-Up

Tuesday, July 1, 2008 09:47 AM

During the DIA 2008 Annual Meeting held in Boston, Phase Forward announced it formed an alliance with AG Mednet to streamline the process of transporting medical imaging, such as MRIs, CAT scans and ultrasounds. The alliance calls for the combining of InForm, Phase Forward’s trial management system, and AG Mednet’s imaging transport network for better tracking and management of patient images in real time from sites to imaging experts. “Clinical trial sponsors need a way to transport patient images more quickly and efficiently for less cost, and a real-time capability to track and manage these images,” said Martin Young Phase Forward’s vice president of corporate development and marketing.

More... »

CWWeekly June 23rd 2008 Issue

Saturday, June 28, 2008 12:45 PM

Top News

More... »

DIA 2008 Wraps up Strong in Boston

Friday, June 27, 2008 02:54 PM

Even in a tough economy and in an industry under many strains, the Drug Information Association’s (DIA) Annual Meeting keeps rolling along and growing.

More... »

Phase I Complexity a Hot Topic at DIA 2008

Thursday, June 26, 2008 05:34 PM

Attempting to gain early efficacy data and examining possible biomarkers in intent-to-treat patients in phase I trials has become more commonplace as sponsors attempt to fill their thinning pipelines. And the use of advanced medical imaging and other diagnostics—especially in cardiovascular and central nervous system studies—has pushed the envelope of what traditional phase I units have handled. In many ways, complexity and an increased need for specialized expertise in early phase research is forcing many smaller phase I organizations to improve their infrastructure and focus on particular disease areas.

More... »

Four Clinical Research Innovators Create Consortium in Massachusetts

Tuesday, June 24, 2008 05:53 PM

Four organizations involved in clinical research have joined together to create the Clinical Research Consortium of Massachusetts (CRCM),  a cooperative enterprise that supports knowledge and technology transfer between Massachusetts and other international regions interested in building clinical research centers of excellence. The group’s first work is with the Lombardia region of Italy.

More... »

Impact on Clinical Research of European Legislation FP7 Project Underway

Monday, June 23, 2008 10:02 AM

The Impact on Clinical Research of European Legislation (ICREL) project is funded by the European Commission’s Seventh Framework Programme (FP7) to measure and analyze the direct and indirect impact of the European Union Clinical Trial Directive 2001/20/EC and EU-related legislation on all categories of clinical research. The one-year ICREL project is being carried out by a consortium composed of the European Forum for Good Practice (EFGCP), European Clinical Research Infrastructure Network (ECRIN), European Organisation for Research and Treatment of Cancer (EORTC), Hospital Clinic I Provincial de Barcelona and the Ethics Committee of the University of Vienna.

More... »